Key result
VExUS score review in cardiorenal syndrome highlights a need for evidence beyond post-surgical cohorts.
Why the study?
Cardiorenal syndrome poses clinical challenges in etiology and monitoring, prompting a need to evaluate evidence for the integrated use of the VExUS score in this setting.
Is the VExUS score useful in the diagnosis and treatment of cardiorenal syndrome?
Is the VExUS score useful in the diagnosis and treatment of cardiorenal syndrome?
While the VExUS score is promising for evaluating congestion in cardiorenal syndrome, current evidence is mostly limited to post-surgical patients, necessitating further research in broader CRS populations.
No takes yet. Share an insight, caveat, or question.
VExUS use in cardiorenal syndrome warrants caution outside post-surgical cohorts; leaves open broader diagnostic and therapeutic utility.
Vázquez et al. (2023) conducted a review in Cardiorenal syndrome (n=13). VExUS score was evaluated. The VExUS score for evaluating venous congestion in cardiorenal syndrome was reviewed across 13 articles, highlighting a need for more evidence beyond post-surgical patient cohorts.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: